title: Comparison of outcomes in studies of advanced Hodgkin's lymphoma.
authors.forename: Peter W M
authors.initials: PW
authors.lastname: Johnson
authors.forename: John A
authors.initials: JA
authors.lastname: Radford
authors.forename: Michael H
authors.initials: MH
authors.lastname: Cullen
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Sydes
authors.forename: Sally P
authors.initials: SP
authors.lastname: Stenning
authors.forename: Barry W
authors.initials: BW
authors.lastname: Hancock
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D012107:Research Design; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin